

Cover Story
																				Thomas Jefferson University is vying to acquire Fox Chase Cancer Center from its current owner, Temple University, the two institutions announced Jan. 10.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Science advocates organize march in DC to demand impeachment of RFK Jr.
- Friends study points to ctDNA’s potential to serve as an intermediate endpoint in NSCLC
 ctMoniTR project aims to improve efficiency in development of intermediate endpoints
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
 
            
















